Results 261 to 270 of about 16,336,802 (316)

Randomized, Double-blind, Placebo-controlled With Open-label Run-in Assessing Efficacy, Tolerability,Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects w/Moderate to Severe, Chronic Pain Due to OA of Knee

Knoa Pharma LLC
openalex   +1 more source

ESG Measurement and Ratings Divergence: A Cross‐Jurisdictional Review of Institutional, Stakeholder, and Digital Accountability Perspectives

Business Strategy and the Environment, EarlyView.
ABSTRACT ESG ratings for the same firm‐year often diverge, shaping capital allocation and accountability. Drawing on a structured systematic‐narrative hybrid review, I synthesize evidence across the European Union, the United States, and China and develop a transnational accountability framework that traces divergence through the measurement pipeline ...
Gary Gang Tian
wiley   +1 more source

Multi-center, Randomized, Double-blind, Placebo-controlled With Open Label run-in Study Assessing Efficacy, Tolerability, Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects With Moderate to Severe, Chronic Low Back Pain

Knoa Pharma LLC
openalex   +1 more source

When Nature Counts: Corporate Biodiversity Attention and Access to Bank Finance

Business Strategy and the Environment, EarlyView.
ABSTRACT This paper investigates whether corporate attention to biodiversity influences firms' access to bank loans, an overlooked question in the emerging biodiversity–finance literature. Using a novel, text‐based measure constructed from 446 biodiversity‐related keywords and applied to Chinese A‐share listed firms from 2000 to 2023, we show that ...
Ruxiao Li, Bo Zhang, Zhang‐Hangjian Chen, Hafiz Hoque   +3 more
wiley   +1 more source

Board Gender Diversity and Circular Business Performance: A Novel Moderated Mediation Framework in Emerging Economies

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines the influence of female directors on circular business performance (CBP), incorporating the mediating role of environmental orientation and the moderating roles of institutional pressure and stakeholder engagement. Drawing on Behavioral Agency Theory and the Natural Resource Based View, we argue that board gender diversity ...
Wu Ning, Ummar Faruk Saeed, Hela Borgi, Maxwell Kongkuah   +3 more
wiley   +1 more source

Open-Label Placebos Are Deceptive and Should Not Be Used in Clinical Practice

Steven Tresker, Pekka Louhiala
openalex   +2 more sources

B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment [PDF]

Nancy Agmon‐Levin, Stanislav Ignatenko, А. В. Гордиенко, Josefina Cortés-Hernández, Pongthorn Narongroeknawin, Katarzyna Romanowska‐Próchnicka, Nan Shen, Hana Ciferská, Masanari Kodera, Wei J Cheng-Chung, Piotr Leszczyński, Joung-Liang Lan, Eduardo Mysler, Rafał Wojciechowski, Tünde Tarr, Еlena A. Vishneva, Yi‐Hsing Chen, Yuko Kaneko, Stephanie Finzel, Alberta Hoi, Masato Okada, Ajchara Koolvisoot, Shin‐Seok Lee, Dai Lie, Hiroshi Kaneko, Bernadette Rojkovich, Lingyun Sun, Eugeny Zotkin, J.-F. Viallard, B. P. Magallares López, Swati Aashish Ghanshani, Carol Lau, Alexandre Avraméas, C. Sips, Stephen J. Oliver   +34 more
openalex   +1 more source

Whose Sustainability Counts? Board Governance, ESG Ratings, and Sustainable Development Goals: Evidence on the ESG–SDG Wedge

Business Strategy and the Environment, EarlyView.
ABSTRACT Institutional investors increasingly rely on ESG ratings to evaluate financially material sustainability risks, while governments promote corporate alignment with the United Nations Sustainable Development Goals (SDGs). Because these frameworks differ substantially in capital market salience and monitoring intensity, board oversight may not ...
Mohamed Hegazy, Diego Prior, Mahmoud Zarea   +2 more
wiley   +1 more source

Open-Label Placebo Effects in Reducing Depression Severity Among Adults with Major Depressive Disorder: A Systematic Review and Meta-Analysis of Early Evidence

Janet Mercedes Arévalo-Ipanaqué, Maria Letícia Gobo Silva, Ricardo Romero-Vucovich, Gianluca Conte, Matheus Gerhard Rosenfeld, Sergio José Fausto Girón, Lisa Gonzalez, Jordy Batista, Sofia Ines Volpi, Maximiliano Espinosa, Daniela Lorena Alvarado Rodriguez, Salvatore Minnella, Tadeus Lopez Ulloa, Nadine Aranis Seguic, Yazmin Heredia Allegretti, Johan Antonio De La Rosa Laureano, Cristian Camilo Bermudez, Letícia Watanabe Koyama, Maria Eduarda Nabhan de Souza, Somaya Althobaiti, Karen Gamonal, Folasade Mary Adeyemi, Luis Pedro Lorenzana, Aderibigbe Adeniyi Sheriff, Peter Benedek, Emilio Vilorio-Alvarez, Wajih Jawhar   +26 more
openalex   +1 more source

The Heterogeneous Impact of Non‐Financial Reporting Directive Legal Implementation on ESG Performance in EU‐Listed Companies

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines the impact of EU Directive 2014/95/EU (NFRD) on the Environmental, Social and Governance (ESG) performance of EU‐listed companies, focusing on variations across ESG dimensions and national institutional contexts. Using a dataset of 19,036 observations from 2010 to 2022, we apply a time‐varying Difference‐in‐Differences ...
Yuqing Xiao, Antonio Somoza
wiley   +1 more source